Typhoid Fever Vaccines Market Scope, Analysis, and Trends by 2031
Typhoid Fever Vaccines Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 376.76 Million |
Market Size by 2031 | US$ 651.87 Million |
Global CAGR (2023 - 2031) | 7.1% |
Historical Data | 2021-2022 |
Forecast period | 2023-2031 |
Segments Covered |
By Vaccine Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Typhoid Fever VaccinesMarket News and Recent Developments
The Typhoid Fever VaccinesMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for Typhoid Fever Vaccines and strategies:
- In November 2023, the Republic of Korea announced a new typhoid vaccine conjugate, "Bio-TCV typhoid conjugate vaccine (TCV)," to be licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority. The new vaccine, "Bio-TCV," is a Vi polysaccharide conjugated vaccine.
Typhoid Fever VaccinesMarket Report Coverage and Deliverables
The “Typhoid Fever VaccinesMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles